TUESDAY, Feb. 03, 2004 (HealthDayNews) -- The U.S. Food and Drug Administration has approved the Pfizer drug Caduet for simultaneous treatment of both high cholesterol and high blood pressure, the company says.
The single pill contains ingredients from both the cholesterol drug Lipitor (atorvastatin calcium) and the blood pressure medication Norvasc (amlodipine besylate).
The two conditions are leading factors for heart attack and stroke, and some 30 million people in the United States have both, Pfizer says.
More than 3,700 people are enrolled in clinical trials, which showed that many participants reached goals for lowering both blood pressure and cholesterol, the company adds in a prepared release.
Check the National Library of Medicine's Medline site for more information about cholesterol and high blood pressure.
